Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural Hypertonic Cisplatin for Malignant Pleural Effusion in NSCLC
NCT02407912Unknown
- Sponsor
- Shantou University Medical College
- Start
- Mar 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cisplatin in malignant pleural effusion (MPE) (2 arms), sponsored by Shantou University Medical College. Primary endpoint: Overall Response Rate at 1 month. Status: unknown.
02
Drugs
cisplatin
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT02407912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407912.